Popular articles
2010
COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION
Y. I. Grinshtein, O. L. Barbarash, D. A. Yakhontov, A. E. Popelysheva, V. V. Shabalin, N. B. Osetrova
Rational Pharmacotherapy in Cardiology
10.20996/1819-6446-2010-6-2-179-184
Aim. To compare efficacy of enalapril and perindopril in patients with arterial hypertension (HT) and left ventricle systolic dysfunction.Material and methods. Patients (n=51) with HT and left ventricle systolic dysfunction (ejection fraction<45%)...
2018
RESPONSIBLE SELF-CARE – THE FUNDAMENTAL PRINCIPLES AND PLACE IN THE MODERN RUSSIAN HEALTHCARE SYSTEM
S. N. Tolpygina, S. Y. Martsevich, A. V. Kontsevaya, O. M. Drapkina
Rational Pharmacotherapy in Cardiology
10.20996/1819-6446-2018-14-1-101-110
An increase in the prevalence of chronic noncommunicable diseases is a significant problem for both patients and the health system. According to the World Health Organization "Promoting effective responsible self-care ... is essential to reduce the f...
2011
COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY
O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko
Rational Pharmacotherapy in Cardiology
10.20996/1819-6446-2011-7-3-300-305
Aim. To compare effects of perindopril and losartan potassium on the parameters of the ambulatory blood pressure (BP) monitoring (ABPM) and circadian BP profile in patients with arterial hypertension (HT) and stenotic coronary atherosclerosis before ...
2021
Effect of metformin therapy on muscle mass and strength in patients with and without diabetes. Meta-analysis of 15 studies
A. V. Sokolova, A. V. Klimova, D. O. Dragunov, G. P. Arutyunov
Russian Journal of Cardiology
10.15829/1560-4071-2021-4331
Aim. To assess the parameters reflecting sarcopenia (body composition, muscle strength, muscle function) in order to determine the effectiveness of metformin in patients with sarcopenia.Material and methods. Systematic searches of clinical trials wer...
2021
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
A. Pelliccia, S. Sharma, S. Gati, M. Bäck, M. Börjesson, S. Caselli, J. Collet, D. Corrado, J. A. Drezner, M. Halle, D. Hansen, H. Heidbuchel, J. Myers, J. Niebauer, M. Papadakis, M. F. Piepoli, E. Prescott, J. W. RoosHesselink, A. G. Stuart, R. S. Taylor, P. D. Thompson, M. Tiberi, L. Vanhees, M. Wilhelm
Russian Journal of Cardiology
10.15829/1560-4071-2021-4488
The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC)
2009
SCHOOL OF HEALTH FOR PATIENTS WITH CARDIO-VASCULAR DISEASES: BALANCE BETWEEN ANDRAGOGIC AND PEDAGOGIC EDUCATIONAL MODELS
S. K. Kukushkin, E. A. Poddubskaya, Y. V. Lukina, M. G. Bubnova
Rational Pharmacotherapy in Cardiology
10.20996/1819-6446-2009-5-2-98-102
Problems of educational programs for patients with cardio-vascular diseases in schools of health are discussed. Comparison of andragogic (adult education) and pedagogic ed�ucation models are analyzed. The pedagogic education model is currently domina...
2020
The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion)
M. V. Ezhov, A. Catapano, C. Escobar, V. V. Kukharchuk, M. I. Voevoda, O. M. Drapkina, S. A. Shalnova, A. V. Starodubova, V. S. Gurevich, I. I. Shaposhnik, O. O. Bolshakova, O. S. Oynotkinova, A. S. Alieva
Rational Pharmacotherapy in Cardiology
10.20996/1819-6446-2020-02-04
The Russian Federation is among countries with high cardiovascular risk. Hypercholesterolemia is a leading risk factor for the development of atherosclerotic cardiovascular diseases. To achieve low-density lipoprotein cholesterol (LDL-C) targets, suc...
2020
2020 Clinical practice guidelines for Chronic heart failure
.. Russian Society of Cardiology (RSC)
Russian Journal of Cardiology
10.15829/1560-4071-2020-4083
Endorsed by the Research and Practical Council of the Ministry of Health of the Russian Federation.
2019
Possibilities of clinical use of ezetimibe Otrio (JSC “AKRIKHIN”, Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts
J. D. Kobalava, V. S. Gurevich, A. M. Galyavich, A. I. Kaminnyi, V. V. Kashtalap, V. Y. Mareev, A. V. Susekov, I. I. Shaposhnik
Kardiologiia
10.18087/cardio.n581
This Conclusion of the Board of experts is devoted to the analysis of the evidence base, the position in modern clinical guidelines, the efficacy and safety analysis as well as the options of combined therapy with statins and ezetimibe (Otrio, JSC “A...
2022
Potential risk factors of atrial fibrillation recurrence after cryoballoon ablation
I. A. Novikov, P. S. Novikov, N. U. Mironov, L. Y. Layovich, T. A. Malkina, M. A. Shariya, S. F. Sokolov, E. B. Maykov
Kardiologiia
10.18087/cardio.2022.6.n1667
Aim To identify risk factors for recurrence of atrial fibrillation (AF) following cryoballoon ablation (CBA).Material and methods This prospective study included patients with paroxysmal AF who had undergone CBA (141 patients, median age 60 yea...
2017
SUBCLINICAL MULTIFOCAL ATHEROSCLEROSIS: SHOULD IT BE DETECTED?
A. N. Sumin
"Arterial’naya Gipertenziya" ("Arterial Hypertension")
10.18705/1607-419X-2017-23-1-69-73
The paper discusses the clinical and prognostic role of multifocal atherosclerosis, namely co-existent atherosclerotic lesions of several arteries. In addition, the issues of the diagnosis of subclinical multifocal atherosclerosis are reviewed.
2019
Grace Risk Score 2.0 predicts acute coronary syndrome outcomes: what marker of myocardial injury should we use?
V. A. Kokorin, M. N. Arefiev, I. G. Gordeev
Complex Issues of Cardiovascular Diseases
10.17802/2306-1278-2019-8-4-37-45
Aim. To compare the effectiveness of various markers of myocardial injury (creatine phosphokinase MB-fraction (CK-MB), cardiac troponin I, measured by standard and high sensitivity methods (cTnI and hs-TnI), and heart-type fatty acids binding protein...